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Abstract 
Galactitol-1-phosphate 5-dehydrogenase (GPDH) is a polyol dehydrogenase that belongs to the medium 
chain dehydrogenase/reductase superfamily (MDR). It catalyses the Zn2+ and NAD+-dependent 
stereoselective dehydrogenation of L-galactitol-1-phosphate to D-tagatose-6-phosphate. Here, we report 
three crystal structures of GPDH from Escherichia coli: the open state of GPDH with Zn2+ in the catalytic 
site and also those of the closed state in complex with the polyols Tris and glycerol, respectively. The 
closed state of GPDH reveals no cofactor bound, which is at variance with the conformational transition 
of the prototypical mammalian liver alcohol dehydrogenase. The main intersubunit-contacting interface
within the GPDH homo-dimer presents a large internal cavity that probably facilitates the relative 
movement between the subunits. The substrate analogue glycerol bound within the active site mimics the 
catalytically relevant backbone of galactitol-1-phosphate. The glycerol binding mode reveals for the first 
time in the polyol dehydrogenases a penta-coordinated zinc ion in complex with a polyol and also a 
strong hydrogen bond between the primary hydroxyl group and the conserved acidic residue Glu144, an 
interaction originally proposed more than thirty years ago that supports a catalytic role for this residue.  
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1. Introduction  
The superfamily of medium chain dehydrogenase/reductase enzymes (MDR) catalyse the reversible 
oxidation of primary and secondary alcohols into aldehydes and ketones, respectively, using NAD(P) as a 
cofactor (Persson et al., 2008). These enzymes comprise a group of different Zn2+-dependent alcohol 
dehydrogenases (EC 1.1.1.1; ADHs), historically typified by yeast and liver ADHs (Riveros-Rosas et al., 
2003). The polyol dehydrogenases (PDHs) form a distinct family that includes sorbitol dehydrogenase 
(EC 1.1.1.14; SDH) (Jeffery & Jörnvall, 1988), xylitol dehydrogenase (EC 1.1.1.9) (Persson et al., 1994) 
and galactitol-1-phosphate 5-dehydrogenase (EC 1.1.1.251; GPDH) (Nobelmann & Lengeler, 1995), 
among many others. 
 Currently, the structures of many MDR enzymes have been solved (Eklund & Ramaswamy, 
2008). Basically, all members share a common subunit architecture that is constructed from two domains, 
a catalytic domain and a nucleotide-binding domain. Between them there is a deep cleft that hosts the 
catalytically requisite Zn2+ ion and the cofactor. These protein subunits associate into homodimeric 
assemblies in mammalian ADHs, or homotetramers in fungal, bacterial and yeast ADHs (Eklund & 
Ramaswamy, 2008), and also in PDHs (Klimacek et al., 2007). Together with the catalytic zinc ion, most 
dehydrogenases from this superfamily have another zinc, which is also located in the catalytic domain, 
particularly within the so-called lobe loop, which is defined as the structural zinc (Auld & Bergman, 
2008) and whose functional role, if any, is not yet clear (Raj et al., 2014). Interestingly, functional 
tetrameric PDHs lack this structural zinc, hence they contain only one metal per subunit (Jeffery & 
Jörnvall, 1988). 
 Whereas the coordination of structural zinc ions with four cysteine residues is, with some 
exceptions (Guy et al., 2003; Pennacchio et al., 2009), essentially conserved (Auld & Bergman, 2008; 
(Raj et al., 2014), the coordination of the catalytic zinc ions is much less homogeneous and is currently 
under intense investigation concerning both the participating ligands and the potential changes occurring 
along the catalytic cycle that would affect the coordination number of the zinc ion (tetra- and penta-
coordinated) or the zinc-ligand bond distances (Ryde, 1995; Baker et al., 2009). Obviously, the 
elucidation of these latter dynamic aspects is relevant to the wider MDR superfamily since they are 
intimately connected to the structural basis of catalysis by these enzymes. In this regard, uncertainties 
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remain about the functional roles of the acidic residues Glu60 (using GPDH numbering) and Glu144, 
both conserved among the PDHs (Eklund et al., 1985; Jeffery & Jörnvall, 1988), which are very close to 
the catalytic zinc. Whereas in this latter family of enzymes Glu60 (Glu68 in horse liver ADH; hlADH) is 
a Zn2+ ligand (Klimacev et al., 2007), Glu144 (Cys174 in hlADH) is linked to the zinc ion through a 
water molecule (also conserved in the family) and thus belongs to the second coordination sphere. In the 
case of hlADH, Glu68, which does not coordinate the metal when in the absence of substrates (the ligands 
to the zinc are Cys46, His67, Cys174 and a water molecule), has been suggested to play different roles, 
namely, a stabilising role in the active site (Al-Karadaghi et al., 1994), modulator of the electrostatic field 
in this environment (Ganzhorn & Plapp, 1988) and also as a transient ligand to the zinc along the catalytic 
cycle, permitting the efficient product release (Ryde, 1995). In other cases, however, substitution of this 
residue by alanine or aspartic acid has minor effects in catalysis (Kleifeld et al., 2003). 
 Regarding Glu144, Eklund et al. (1985) originally proposed that this residue would be involved 
in substrate binding in PDHs by specifically forming a strong hydrogen bond with the primary hydroxyl 
group adjacent to the secondary hydroxyl group undergoing reaction. Despite no direct structural 
evidences exist supporting this idea, the crystal structure of human SDH in complex with NADH and the 
inhibitor CP-166,572 (PDB entry: 1pl6) is consistent with this hypothesis, revealing a 2.4 Å H-bond 
between the side chain of Glu144 (Glu155 in SDH) and the primary hydroxyl group of the inhibitor 
(Pauly et al., 2003). Moreover, kinetic isotope effect studies with xylitol dehydrogenase from the yeast 
Galactocandida mastotermitis identified a role for this residue as a modulator of general base catalysis, 
not being essential for hydrogen transfer (Klimacek et al., 2007).  
  Conversely, catalysis by hlADH is intimately linked to conformational flexibility and in fact this 
protein was one of the first enzymes for which different conformational states were reported for apo- and 
holo-forms (Brändén, 1965). Nevertheless, despite much is known about these conformational changes 
(Plapp, 2010), the connections between protein dynamics and catalysis are not well understood. Basically, 
the main conformational changes in hlADH that have been identified during catalysis are: a global 
conformational change affecting the relative orientation of catalytic and cofactor-binding domains that 
occurs upon binding of the coenzyme, and loop rearrangements around residues 292-299 of the coenzyme 
binding domain. Other minor changes affecting the active site result from the exchange of zinc ligands, 
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perhaps involving penta-coordinated zinc intermediates (Dworschack & Plapp, 1977; Makinen & Yim, 
1981). The predominant scenario explaining these conformational changes is that of the induced fit, 
namely, the enzyme changes conformation upon binding of substrates (Plapp, 2010) and, particularly for 
hlADH, it has been shown that binding of the complete coenzyme is required for the transition between 
the open state (apo-form) and the closed state (holo-form) (Eklund & Ramaswamy, 2008). Nevertheless, 
it is not clear that this transition is required for catalysis because the catalytic residues occupy similar 
positions in both forms; in this regard, only minor changes have been observed between the apo- and 
holo-forms in human SDH (Pauly et al., 2003).  
 The crystal structures of GPDH that we report in this work offer novel details for the PDH family 
on several enzymatic issues that may be relevant for the wider MDR superfamily. Thus, the structure of 
the apo-form reveals that, in contrast to the currently known crystal structures of PDHs, GPDH has a 
structural Zn2+ per subunit in addition to the catalytic metal ion. Furthermore, the structure of the closed 
state obtained in complex with the substrate analogue glycerol reveals key structural features: for the first 
time the Zn2+ is observed penta-coordinated with a polyol that is structurally homologous to the 
catalytically relevant part of the substrate; secondly, also at variance with PDHs, Glu60 is not a ligand to 
the Zn2+; and, thirdly, this complex reveals the originally predicted strong hydrogen bond between the 
primary alcohol and Glu144 while the secondary alcohol is directly coordinating the Zn2+. Finally, it is 
remarkable that the closed state of GPDH is observed with substrate analogues within the active site but 
in the absence of bound cofactor. 
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2. Materials and methods 
2.1. DNA manipulations 
 The expression vector pT77-GPDH coding for the wild-type galactitol-1-phosphate 5-
dehydrogenase from Escherichia coli (K12) (Esteban-Torres et al., 2012) was used as template for the 
preparation of single-point variants affecting residues located in the active site region of GPDH (Ser40, 
Arg44, His51, Tyr106 and Arg112) by site-directed mutagenesis PCR. The mutagenic primers used 
(forward and reverse, respectively) were: S40A-fw (5´-GCTTATGTGGTGCCGATTTACC-3´) and 
S40A-rv (5´-GGTAAATC GGCACCACATAAGC-3´) for the Ser40Ala variant; R44T-fw (5´-
CGATTTACCCACCATATTTAAA AATGG-3´) and R44T-rv 
(CCATTTTTAAATATGGTGGGTAAATCG-3´) for the Arg44Thr variant; H51A-fw (5´-
GGTGCAGCTTATTATCC-3´) and H51A-rv (5´-GGATAATAAGCTGCACC-3´) for the His51Ala 
variant, Y106A-fw (5´- GTGCGCAAAAGCTGATTTTATTGG-3´) and Y106A-rv (CCAATA 
AAATCAGCTTTTGCGCAC-3´) for the Tyr106Ala variant, and finally, R112A-fw (5´-
GGCTCAGCGCGTGATGGTGGATTTG-3´) and R112A-rv (5´-AATCCACCATCACGCGCTGAGCC-
3´) for the Arg112Ala variant. The mutated GPDH genes were sequenced to verify the expected 
nucleotide changes. 
2.2. Protein Expression and Purification 
 Wild-type and single-point mutants of GPDH were produced and purified essentially as 
previously described (Esteban-Torres et al., 2012). Briefly, cells carrying the corresponding recombinant 
plasmid were grown at 37 ºC in LB media containing ampicillin (100 µg/ml) and induced by adding 0.4 
mM isopropyl--D-thiogalactopyranoside. After induction, the cells were grown at 22 ºC during 20 h and 
collected by centrifugation using a Beckman Coulter J-25 Avanti centrifuge (7500 x g for 15 min at 4 ºC). 
Cells were resuspended in 20 ml of 20 mM Tris-HCl, pH 8.0 containing 100 mM NaCl per liter of cell 
culture. Crude extracts were prepared by French Press lysis of cell suspensions. The lysate was 
centrifuged at 17,400 x g for 40 min at 4 ºC using a Beckman Coulter J-25 Avanti centrifuge. The 
supernatant was filtered through a 0.22 µm filter (Millipore) and subsequently loaded onto a HisTrap-FF 
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column (GE Healthcare) previously equilibrated in binding buffer (20 mM Tris-HCl, pH 8.0 containing 
100 mM NaCl and 10 mM imidazole). The recombinant proteins were eluted with a linear gradient of 
imidazole (from 10 mM to 500 mM) with an ÄKTA Prime Plus. Fractions containing the target protein 
were pooled and concentrated by ultrafiltration. The protein (2 mL) was then loaded onto an ion exchange 
HiTrap Q HP column (GE Healthcare) equilibrated in 20 mM Tris-HCl, pH 8.0 containing 10 mM NaCl. 
The elution of the proteins was carried out with a linear gradient of sodium chloride (from 10 mM to 500 
mM). As before, fractions containing the target protein were pooled and concentrated by ultrafiltration. 
The final purified material was stored at -80º C until use. 
The preparation of the binary complex [GPDH:Zn2+] was done as follows: first, wild type GPDH 
(10 mg/ml) in Tris buffer, pH 8.0 (20 mM Tris-HCl, pH 8.0, 100 mM NaCl) was buffer exchanged to 
zinc-containing buffer (20 mM Tris-HCl, pH 9.0, 100 mM NaCl, 0.5 mM zinc chloride), with a HiTrap 
desalting column (GE Healthcare). The eluted protein was concentrated up to 12 mg/ml for crystallization 
trials or used as starting material for preparation of the tertiary complex [GPDH:Zn2+:NAD+]. In this case, 
NADH was added to the protein solution up to a final concentration of 1.8 mM and incubated overnight at 
4º C. The mixture was then concentrated and loaded onto a HiTrap desalting column (GE Healthcare) 
equilibrated in Tris buffer, pH 8.0. The eluted protein was concentrated to 12 mg/ml for crystallization 
trials. UV-VIS absorbance scans of this protein stock solution showed a maximum at 340 nm indicating 
the presence of NADH. 
2.3. Synthesis of galactitol-1-phosphate and activity assays 
 L-Galactitol-1-phosphate (LG1P) and D-galactitol-1-phosphate (DG1P) were synthesized and 
verified by Elexopharm, Saarbruecken, Germany (www.elexopharm.de). All enzymatic tests were 
performed in duplicate. Catalytic constants for the oxidation of LG1P were determined in 100 mM Tris-
HCl buffer pH 9.0, containing 0.5 mM ZnCl2, 1.8 mM NAD+ and concentrations of GPDH variants 
between 4 and 50 µg/ml, respectively. The reaction was started by addition of the substrate and the 
change of extinction was followed at 340 nm using an Ultrospec 2100 pro photometer from GE 
Healthcare. For inhibition experiments 1 or 3 mM DG1P were added to the buffer prior to reaction start 
with LG1P.   
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 Protein concentrations were determined by the method of Pierce (BCATM Protein Assay) with 
bovine serum albumin as the standard (Smith et al., 1985). 
2.4. Crystallization
 Whereas GPDH incubated with Zn2+ crystallized in the same experimental conditions as those 
described previously (Esteban-Torres et al., 2012), conditions for crystallization of GPDH incubated with 
Zn2+ and NAD(H) were determined de novo by the sitting-drop vapour diffusion method with commercial 
screens from Hampton Research (Riverside, California, USA) and Qiagen in Innovaplate SD-2 96-well 
plates set up using a Nanodrop Innovadyne robot. Each drop contained 250 nl of protein (12 mg/ml) in 
TrisHCl buffer (20 mM TrisHCl pH 8.0 containing 0.1 M NaCl) and 250 nl of reservoir solution. 
Drops were equilibrated against 65 µl reservoir solution. Initial crystals were observed in 20% (w/v) PEG 
6000, 0.1 M Tris-HCl, pH 8.0, 0.2 M CaCl2, and also in 15% (w/v) PEG 4000, 0.1 M Tris-HCl, pH 8.5, 
0.2 M magnesium chloride. After scaling up and optimization of the crystallization conditions using 
hanging drops in 24-well VDX plates high quality diffracting crystals where prepared in 16% (w/v) PEG 
4000, 0.2 M magnesium chloride, 0.1 M Tris-HCl, pH 8.5 (2:1 protein:precipitant volume ratio; total 
volume 3 µl). 
2.5. Data collection, processing and structure solution
 Crystals suitable for X-ray analysis were transferred to an optimized cryoprotectant solution 
(reservoir solution plus 20% (v/v) glycerol) for ~5-10 secs (2 minutes for the crystal measured on 
beamline ID23-1) and then cryocooled at 100 K in the cold nitrogen-gas stream. Diffraction data from 
crystals of GPDH preincubated with Zn2+ were recorded on BL13-XALOC beamline at the ALBA 
Synchrotron (Barcelona, Spain) at the zinc peak (9.667 keV; 1.28245 Å wavelength) as determined 
experimentally from the corresponding fluorescence energy scan. A Pilatus 6M detector (Area Detector 
Systems Corp.) was used with a crystal-to-detector distance of 268.14 mm, and a total of 360 images 
were collected with a 0.5º oscillation angle. Conversely, two datasets from crystals prepared with GPDH 
preincubated with Zn2+ and NADH were collected on beamlines ID29 and ID23-1 at the ESRF (Grenoble, 
France) using wavelengths of 1.28149 and 0.96885 Å, respectively. Whereas the crystal measured on 
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beamline ID29 was incubated for ~5-10 s in the cryoprotectant solution, the one measured in ID23-1 was 
incubated for ~2 minutes. In both cases, the detector was a Pilatus 6M. A total of 3600 images were 
collected on beamline ID29, with a 0.10º oscillation angle and a crystal-to-detector distance of 317.48 
mm. The dataset from beamline ID23-1 consists of 2400 images collected with a 0.15º oscillation angle 
and a crystal-to-detector distance of 188.84 mm. Diffraction images were processed with the XDS
(Kabsch, 2010) program package. Space group examination was done with POINTLESS (Evans, 2011) 
and intensities reduction with AIMLESS (Evans, 2011) from the CCP4 suite of programs (Winn et al., 
2011). The first crystal form (GPDH incubated only with Zn2+) belonged to the monoclinic space group 
P21, with unit cell parameters a = 43.31, b = 76.91, c = 108.65 Å,  = 95.51º, and is herein defined as 
crystal form I. Conversely, crystals from GPDH preincubated with Zn2+ and NADH were also monoclinic 
(space group P21), with unit cell parameters a = 65.31, b = 78.81, c = 68.24 Å,  = 94.75º, and are defined 
as crystal form II. Data statistics are summarized in Table 1. 
2.6. Structure determination and refinement 
 The crystal structure was determined by molecular replacement using the program Phaser 
(McCoy et al., 2007). The atomic coordinates of GPDH (PDB code: 4a2c) were used as a search model. 
Model rebuilding was done manually using Coot (Emsley et al., 2010) and the refinement was performed 
with phenix.refine (Afonine et al., 2012) in Phenix (Adams et al., 2010). Refinement steps included xyz
refinement, TLS, individual atomic displacement parameters (ADPs), addition of ligands, and automatic 
addition of water molecules using default parameters. Stereochemical validation was carried out using the 
program MOLPROBITY (Chen et al., 2010). Refinement statistics are shown in Table 1. The final model 
from crystal form I (model 1) has an R-factor of 19.3 % and an Rfree of 25.7 %, and included 692 amino 
acid residues, 5 zinc ions and 276 solvent molecules. Model 2 (the one obtained from crystal form II 
measured at ID29) has an R-factor of 20.2 % and an Rfree of 25.5 %, and included 692 amino acid 
residues, 5 zinc ions, 2 Tris molecules and 471 solvent molecules, and model 3 (obtained from crystal 
form II measured at ID23-1) has an R-factor of 18.5 %, Rfree of 22.9 %, and included 692 amino acid 
residues, 5 zinc ions, 2 glycerol molecules and 654 solvent molecules. Ribbon diagrams were prepared 
using PyMOL (DeLano, 2008). 
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2.7. Computational methods 
 To account for substrate and cofactor recognition the three-dimensional coordinates of the 
enzyme structure in the apo-form were used to build a model of the Michaelis complex. Initial positions 
for the NAD+ cofactor and the catalytic zinc ion were obtained from the best-fit superimposition of this 
apo form onto Neurospora crassa L-arabinitol-4-dehydrogenase (PDB code 3m6i) using the structural 
alignment tool implemented in PyMOL. The location of the cofactor was compared to that found in other 
related dehydrogenases from the same MDR superfamily and it was established that the key ligand-
protein interactions were present. The geometry of the resulting complex was optimized by following an 
energy minimization protocol consisting of 2000 steps of steepest descent followed by 3000 steps of 
conjugate gradient. The AMBER 10 force field and published parameters for NAD+ (Ryde, 1995) were 
employed. To place the LG1P and DG1P molecules inside the active site of the modeled enzyme, we used 
our in-house CRDOCK docking program (Cortés et al., 2012) and default parameters. The binding poses 
obtained for each molecule were ranked according to the calculated interaction energies but also taking 
into account the feasibility of the enzymatic reaction on the basis of the distances separating C5 of LG1P 
from C4 of NAD+ molecule ( 4.0 Å) and the O5 and O6 atoms from the zinc ion ( 2.5 Å). By following 
this procedure we were able to select the most likely binding orientations for both substrates within the 
enzyme active site. 
2.8. PDB accession codes 
Atomic coordinates and structure factor amplitudes have been deposited in the Protein data Bank 
and are available under the accession codes 4ueo (open state of GPDH with Zn2+ in the catalytic site), 
4uej (closed state of GPDH with glycerol in the active center) and 4uek (closed state of GPDH with Tris 
in the active center).  
3. Results and discussion 
3.1. Overall structure of the GPDH monomer and some comments of the two crystal 
forms 
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 Two different monoclinic crystals of GPDH have been prepared in this work. Crystal form I is 
herein defined as the one corresponding to crystals of GPDH that have not been incubated with NADH; it 
contains in the catalytic metal-binding site either nickel scavenged during purification (Esteban-Torres et 
al., 2012) or externally added zinc (this work; PDB entry: 4ueo). Conversely, crystal form II corresponds 
to crystals of GPDH that has been incubated with Zn2+ and NADH [this work; PDB entries: 4uek (model 
2) and 4uej (model 3)]. Despite these latter incubation conditions permitted the reconstruction of the 
holoenzyme in solution as revealed spectroscopically (not shown), no electron density assignable to the 
cofactor is observed. The comparison of the structure of GPDH from crystal form II (either model 2 or 3) 
with that from crystal form I (model 1) reveals a global conformational change in GPDH, similar to the 
classical one undergone by horse liver ADH (hlADH) upon cofactor-binding (Plapp, 2010). This 
conformational change mainly involves a relative orientation of the two subdomains of the protein 
subunits (see below) and therefore it does not affect the description of the overall structure of GPDH 
subunits. For this, we have arbitrarily chosen molecule A from crystal form II (subunit conformation of 
models 2 and 3 are essentially indistinguishable) as reference.  
The GPDH monomer comprises 346 amino acid residues, arranged in two distinct subdomains, as 
typically observed in members of the medium-chain dehydrogenase/reductase (MDR) superfamily 
(Eklund & Ramaswamy, 2008): a discontinuous, large catalytic domain (residues 1-148 and 286-346) and 
a smaller cofactor-binding domain (residues 149-285) (Figure 1). The subdomains are separated by a 
deep cleft where the active site is located and therefore where the NAD(H) cofactor, the catalytic zinc and 
the substrates are accommodated (Eklund & Ramaswamy, 2008). The cofactor-binding domain is a 
canonical Rossmann fold, characteristic of NAD(H)-binding proteins (Bellamacina, 1996; Fan & Plapp, 
1999), which is made up of a six-stranded parallel -sheet surrounded by -helices.  
Conversely, the core of the catalytic domain is formed by a seven-stranded mixed β-sheet [five 
antiparallel (3, 4, 5, β6 and 7) and two parallel (15, 16)  strands], which is flanked by a two-
stranded antiparallel -sheet (1, 2) and three -helices (1, 310-3 and 10). The main contacting regions 
between these two subdomains arise from the loop that houses the structural zinc-binding site (lobe loop), 
which interacts with two connecting loops from the other subdomain (loop between strand 14 and helix 
9 and the loop between helices 310-3 and 4). As also observed in other members of the MDR 
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superfamily, a distinct kink is present within the 310-3 helix preceding the position of the functionally 
relevant Glu144 (see below).  
Two bound metal ions per GPDH subunit are identified in both crystal forms, which are here 
unambiguously identified as zinc. This observation agrees with the fact that most NAD(H)-dependent 
dehydrogenases from the MDR superfamily have two zinc ions per subunit (Auld & Bergman, 2008), 
namely one catalytic zinc within the active site and another one located in the lobe loop of the catalytic 
subdomain, but it is at variance with the known structures of functional, tetrameric PDH enzymes, which 
lack the structural zinc (Jeffery & Jörnvall, 1988). In contrast to this, in some bacterial MDR alcohol 
dehydrogenases this zinc-containing loop has been shown to be important for tetramer formation 
(Banfield et al., 2001; Esposito et al., 2002; Guy et al., 2003). Thus, GPDH is a peculiar PDH insofar as 
it is dimeric and contains two zincs per subunit. In fact, we found that bacterial, dimeric MDR enzymes 
are reductases but they lack zinc ions (Edwards et al., 1996; Shimomura et al., 2003; Sulzenbacher et al., 
2004). 
As expected, matching a GPDH subunit against the PDB using the DALI server (Holm & Sander, 
1995) revealed that the closest structural homologs belong to ADHs and PDHs enzymes from the MDR 
superfamily, in particular, a putative zinc-binding dehydrogenase from Sinorhizobium meliloti (PDB 
entry: 4ejm; rmsd 2.0 Å for 332 C-atoms), L-threonine dehydrogenase from Pyrococcus horikoshii 
(Ishikawa et al., 2007) (PDB entry: 2dfv; rmsd 1.9 Å for 331 C-atoms), ketose reductase (sorbitol 
dehydrogenase) from silverleaf whitefly (Banfield et al., 2001) (PDB entry: 1e3j; rmsd 1.9 Å for 331 C-
atoms), L-threonine 3-dehydrogenase from Thermus thermophilus (PDB entry: 2dq4; rmsd 2.0 Å for 336 
C-atoms), L-threonine dehydrogenase from Thermococcus kodakaraensis (Bowyer et al., 2009) (PDB 
entry: 3gfb; rmsd 2.0 Å for 334 C-atoms), human sorbitol dehydrogenase (hSDH) (Pauly et al., 2003)
(PDB entry: 1pl8; rmsd 2.1 Å for 335 C-atoms), and also many other ADHs with rmsd values around 2 
Å. The result reveals a remarkably high degree of conservation of the architecture of the protein subunits 
despite the low level of sequence identity among them (less than 27%) (Figure 1).  
3.2. Quaternary structure and the built-up of an internal cavity 
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 In contrast to bacterial ADHs and PDH enzymes, which are tetrameric assemblies, GPDH is a 
dimer both in solution and in the crystal (Esteban-Torres et al., 2012). The association between GPDH 
subunits occurs through their cofactor-binding subdomains. The main contacting interface buries 
approximately 3450 Å2 per dimer and results from the contacts between the 12-13 connecting loop, 
strands 13 and 14 and helix 8 from each subunit (Figure 2). It is remarkable that, upon dimer 
formation, these structural elements, together with helix 7 and strand 12 from each subunit, delimit an 
internal, large solvent inaccessible cavity (310 Å3 in volume as estimated with the CASTp server [Dundas 
et al., 2006]) (Figures 3a and 3b) lined exclusively with hydrophobic residues (Val243, Val247, Leu256, 
Leu258, Leu266, Leu268, Phe273, Ile276, Val283) (Figure 3c). The overall shape of this cavity is that of 
a rectangular prism: one of its sides is surrounded by the two-stranded, intersubunit, antiparallel β-sheet 
formed by strands β13, whereas the opposite side is defined by strands 12 and 14 from each subunit. 
One pair of perpendicular and opposed faces of the cavity would be formed by helix 8 from one subunit 
and the 12-13 connecting loop from the other one, whereas the other opposed pair of faces would be 
defined by helices 7. As far as we know, similar cavities have not been described previously for any 
other enzyme from the MDR superfamily, irrespective of the highly conserved protein architecture of 
these proteins. On the contrary, all the structural homologues found for GPDH have tightly packed 
hydrophobic cores in the equivalent regions. 
 As expected by the crucial location at the intersubunit-contacting interface, there exist structural 
elements of GPDH that probably contribute to stabilize the dimeric assembly. In particular, helix 8 
(residues 270-278) is an important intersubunit secondary structure element, together with strands 12 
and 14. This helix participates in several intersubunit contacts: (i) a cation-π interaction between Arg278 
and Trp287, (ii) a salt bridge between Glu280 and His151 (2.3 Å), and (iii) a hydrophobic cluster formed 
by Phe273 and Leu277, on the one hand, and residues Val243, Leu258 and Leu262 from the contacting 
subunit, on the other hand. We believe that, in contrast to these intersubunit-stabilizing interactions, the 
presence of a large, internal cavity at the intersubunit interface should be considered a priori a 
destabilizing factor, essentially due to the inefficient packing of hydrophobic side chains. In fact, it is well 
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known that cavity-creating mutations within hydrophobic cores in proteins are generally destabilizing 
(Eriksson et al., 1992; Jackson et al., 1993; Buckle et al., 1996).  
 Although the electron density map does not reveal any ordered water molecule within the cavity, 
in agreement with the low probability of finding a single water molecule in a small hydrophobic cavity (1 
in 20,000) (Wolfenden & Radzicka, 1994), the existence of water molecules in large hydrophobic cavities 
in proteins is contentious (Matthews et al., 1995) perhaps because of the assumption that lack of density 
in a crystallographic electron density map means absence of matter (Yu et al., 1999). Although these 
maps did not usually reveal any atom whose average position is ill defined, a large body of studies on 
hydrogen exchange shows that solvent can penetrate deepest into the protein structure (Eglander & 
Kallenbach, 1983). For this reason, we think it is reasonable to propose the existence of mobile solvent 
within the observed cavity of GPDH, which may play a role in protein dynamics. In this regard, in this 
work we have identified two distinct conformational states in GPDH (open and closed states, 
respectively), which are similar to those originally identified in hlADH (Plapp, 2010). Comparison 
between these two conformational states reveals displacements of side chains facing the cavity, which 
most probably occur in synchrony with the global conformational change of GPDH. Considering these 
observations, we claim that the cavity, filled with mobile, internal molecules would be a structural 
outcome that integrates both flexibility to the main intersubunit interface allowing significant 
conformational changes to occur, and stability that would preserve the dimeric assembly.  
3.3. A global conformational change in GPDH 
 As indicated above, we have crystallized the binary complex GPDH incubated with Zn2+ (crystal 
form I) and also made crystallization trials with the tertiary complex [GPDH:Zn2+:NADH], which 
rendered new monoclinic crystals (crystal form II). Despite the fact that the phased-model difference 
Fourier map of GPDH calculated with data from these latter crystals did not reveal any electron density 
assignable to the NADH cofactor, this latter structure (either model 2 or 3), when compared to model 1, 
reveals the existence of a global conformational change in GPDH similar to that reported for hlADH 
occurring upon binding of the complete cofactor (Plapp, 2010). Hence, two distinct conformational states 
for GPDH are identified: an open state derived from the crystal form I (equivalent to the open state of 
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hlADH obtained with the apo-enzyme), and a closed state, derived from crystal form II (equivalent to the 
closed state of hlADH, obtained with the holo-enzyme). The conformational change in hlADH can be 
described as a rigid body rotation between the catalytic and cofactor-binding subdomains (Plapp, 2010), 
together with some rearrangements in the 292-299 loop involved in cofactor binding (12-13 connecting 
loop in GPDH).  
Similarly to hlADH, the observed conformational change in GPDH involves a relative motion of 
the catalytic and cofactor-binding subdomains, with helices 9 and 310-3 acting as hinges. This movement 
leads to a closure of the cleft between subdomains where the active site is located. In particular, the N-
terminal end of helix 1 and the 10-16 connecting loop, both from the catalytic subdomain, and helix 
5 and connecting loops between strand 8 and helix 4, and between strands 12 and 13, from the 
cofactor-binding subdomain, approach the center of the cleft, narrowing its overall width.  
When analyzed at the dimeric assembly level, the reorientation of the GPDH subdomains of both 
subunits results in an in-plane, antiparallel displacement of one 13 strand relative to the other, and also a 
change in the relative position of helix 8 from one subunit with respect to the 12-13 connecting loop 
from the other subunit. Conversely, strands 12 and 14 from the extended intersubunit -sheet remain 
stationary, probably contributing to the integrity of the dimer as the conformational change occurs, 
similarly to helices 8. In fact, several intersubunit interactions are identified at both sides of strands 12 
and 14: polar interactions between Glu280 with His151 and with carbonyl oxygen of Trp287, and 
stacking interactions between the aromatic rings of His253 and Phe99 side chains. Interestingly, the 
imidazole ring of His151 is highly oriented since it is bridged between Glu280 from the other subunit and 
Glu298. 
Normal mode analyses of GPDH with the web server ElNémo (Suhre & Sanejouand, 2004) 
reveals that a single normal mode (second normal mode for a single subunit and first normal mode for the 
dimer) reproduces a conformational transition between an open and a closed conformation of the enzyme 
in both directions (open → closed and closed → open), in which the crystal structures of GPDH would be 
snapshots lying along the pathway connecting such conformations.   
 As indicated above, residues facing the internal cavity of GPDH participate in the global 
conformational change. The observed antiparallel displacement of strands 13 involves an in-plane 
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translation of the Leu266 and Leu268 side chains within the cavity, whereas the movements affecting to 
helices 8 and the 12-13 connecting loops involve the displacements of Leu262, Phe273 and Ile276 
side chains. As above indicated, these internal displacements of side chains are probably facilitated by the 
presence of the internal cavity, where solvent molecules in protein dynamics may play a role.  
 Curiously, supporting evidence for a role of the cavity as a facilitator for the intersubunit 
conformational change may come also from hlADH. In this case, the observed conformational change has 
no effect on the dimeric assembly of hlADH in the sense that intersubunit contacting surfaces are not 
affected by the reorientation of protein subdomains. Here, the remarkable observation is that, contrary to 
GPDH, hlADH has no internal cavity but a highly packed hydrophobic core. This hints at a correlation 
between the presence of an internal cavity (lack of a tightly packed hydrophobic core) and the existence 
of local conformational changes at the dimer interface. Obviously, these observations raise numerous 
questions as to which are the relationships between the specific catalytic mechanisms of the different 
ADHs and the diverse conformational degrees of freedom provided by the intersubunit dynamics. 
 Finally, it is noteworthy that the closed state of GPDH is observed with no cofactor bound but 
containing Tris or glycerol within the active site. This may suggest either that the binding of these 
molecules induces such a conformational transition in the absence of cofactor or the existence of a 
conformational equilibrium between open and close states in the absence of ligands, which in our studies 
would probably be selected by the different crystallization conditions. Although, as far as we know, this 
would be a novelty for any MDR enzyme where the scenario is dominated by the induced fit concept 
(Plapp, 2010), the conformational selection scenario is a well-known phenomenon in enzymatic systems 
(Changeux, 2013). In fact, it has been proposed that both situations are not mutually incompatible but 
limiting cases of a more general framework that integrates both phenomena (Hammes et al., 2009).
3.4 Metal ligands  
 Prior characterization of GPDH revealed the necessity of Zn2+ and NAD(H) for oxidation of 
galactitol and for reduction of D-tagatose-6-phosphate (Esteban-Torres et al., 2012). The metal-binding 
sites of GPDH that we reported previously revealed two metals bound per protein subunit: one Zn2+
bound in the structural metal-binding site, and another metal located in the catalytic site that we proposed 
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to be a nickel scavenged from the purification media (Esteban-Torres et al., 2012). Now, new crystals of 
GPDH incubated with Zn2+ have permitted the unambiguous identification of the two metals as Zn2+, as 
revealed by X-ray energy scans and also from anomalous difference maps calculated with data recorded 
at the Zn peak (9.667 keV) (Figure 4). 
The structural zinc ion, in all the structures reported here, is located in the lobe loop of the 
catalytic domain (residues 89-103) where it is coordinated by four cysteine residues (Cys89, Cys92, 
Cys95, and Cys103), with a tetrahedral geometry (Figure 4a). In this type of coordination where Zn2+
forms four strong bonds with cysteine residues the metal does not normally dissociate in biological 
conditions (Harding et al., 2010), usually playing a role in the stabilization of the tertiary structure. This 
structural metal is also observed in the crystal structures of the close homologs L-threonine 
dehydrogenases from Pyrococcus horikoshii (Ishikawa et al., 2007) and from Thermus thermophilus 
(PDB entry: 2dfv) or whitefly ketose reductase (Banfield et al., 2001), but neither in hSDH (Pauly et al.,
2003), sheep liver sorbitol dehydrogenase (Yennawar et al., 2011) nor in L-threonine dehydrogenase 
from Thermococcus kodakaraensis (Bowyer et al., 2009). This variability in the structural metal binding-
site correlates well with the variation in the total zinc content observed in general for other more distant 
ADHs (Bogin et al., 1997; Korkhin et al., 1998; Sulzenbacher et al., 2004).  
Although the structure of GPDH determined from crystals of form I (model 1) reveals a Zn2+ in 
each catalytic site, the low metal occupancy deduced from B-factor analysis (Zn2+ overall B-factor: 125 
Å2 vs ligands overall B-factor: 63 Å2) makes the geometry of metal coordination not as reliable as those 
determined from GPDH models 2 or 3 in which full metal occupancy is observed (model 2: Zn2+ overall 
B-factor: 27 Å2 vs ligands overall B-factor: 18 Å2; model 3: Zn2+ overall B-factor: 20 Å2 vs ligands overall 
B-factor: 25 Å2). Nonetheless, it can be easily ascertained in model 1 that the metal is coordinated by 
Cys38, His59 and two water molecules (Figure 4b). 
Unexpectedly, a different metal coordination is observed for each of the GPDH models from 
crystal form II (models 2 and 3), which results from the presence of different polyols in the active site that 
are ligands to the zinc: whereas in model 2 a Tris molecule is identified in the active site, a glycerol is 
observed in model 3. Most probably, these complexes resulted from the different incubation times of 
GPDH crystals in the cryoprotectant solution. Thus, short times (~5-10 secs) yielded GPDH crystals with 
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Tris in the active site and longer ones (2-3 minutes) led to the replacement of the Tris molecules by 
glycerols. Since this latter molecule is structurally analogous to the catalytically relevant region of 
galactitol-1-phosphate, the complex may reveal interactions that most probably occur between GPDH and 
LG1P.  
In model 2 of GPDH the catalytic zinc is coordinated by residues Cys38, His59, a water molecule 
and hydroxyl OH1 from the Tris molecule (Figure 4c). In model 3, however, the zinc is penta-
coordinated by Cys38, His59, a water molecule and OH1 and OH2 hydroxyls of glycerol. The shape of 
the coordination is a distorted tetragonal pyramid (Figure 4d), typical for 5-coordination [54]. In this 
case, the most distorted angle is observed between atoms N2/Zn2+/O(OH1), most probably due to the 
formation of an additional interaction: a strong hydrogen bond to O2 atom from Glu144 (distance 2.4 Å). 
On the contrary, hydroxyl group OH2 (equivalent to the hydroxyl group of LG1P undergoing reaction) 
exclusively interacts with the metal.  
We believe that these latter structural results are remarkable in several aspects: firstly, the 
existence of the interaction between OH1 and the Glu144 side chain shows that this residue is an essential 
element of PDH-specific substrate recognition and catalysis. This idea was anticipated almost thirty years 
ago by Eklund et al. (1985) for a model of sorbitol dehydrogenase and is here validated for the first time 
with a polyol molecule within the active site. Secondly, the structure of bound glycerol supports the 
binding mode of sorbitol by human sorbitol dehydrogenase, as proposed by Pauly et al. (2003) in that C1 
and C2 oxygen atoms of sorbitol would coordinate the zinc leading to a penta-coordinated intermediate. 
Thirdly, this complex with glycerol is, as far as we know, the first structure revealing a Zn2+ in the PDHs 
that is penta-coordinated with a polyol that is a substrate analogue that participates in metal coordination. 
In truth, the crystal structure of human sorbitol dehydrogenase complexed with NADH and the inhibitor 
CP-166,572 (Pauly et al., 2003) (PDB entry: 1pl6) also reveals a penta-coordinated Zn2+, although this 
inhibitor is not a polyol. Furthermore, among the ADHs the only structures presenting a penta-
coordinated zinc are the binary complex between hlADH and 1,10-phenanthroline (Boiwe & Brändén, 
1977), which is not an alcohol, and two other crystal structures (H. sapiens ADH3; PDB entries: 1m5c 
and 1teh), in which one Zn2+ coordination is established with a water molecule at distances around 3 Å 
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that markedly depart from the average metal-water atom distance derived from the Cambridge Structural 
Database (2.09 ± 0.05) Å (Harding et al., 2010). 
3.5. Further analysis of the GPDH active site  
The structures of GPDH with Tris or glycerol within the active site reveal features that may be 
relevant to the wider MDR superfamily, in particular, aspects related to the couple of acidic residues close 
to the zinc center (Glu60 and Glu144 in GPDH). The acidic residue Glu144 is conserved among the 
PDHs (Jeffery & Jörnvall, 1988) and is not a ligand to the Zn2+, but coordinates the metal via a water 
molecule whose conserved character in PDHs [human (Pauly et al., 2003) and sheep (Yennawar et al., 
2011) sorbitol dehydrogenases and whitefly ketose reductase (Banfield et al., 2001)] suggests it may play 
a role in catalysis (Klimacek et al 2007). In GPDH, this solvent molecule also interacts with the 
accompanying acidic residue Glu60, which similarly to Glu144 does not coordinate the Zn2+. The role of 
Glu60 in catalysis in MDR enzymes in general, and in PDHs in particular, is not clear although it has 
been proposed that it may coordinate the Zn2+ along the catalytic cycle (Ryde, 1995). In agreement with 
this, Glu60 coordinates the Zn2+ in sheep sorbitol dehydrogenase (Yennawar et al., 2011) and whitefly 
ketose reductase (Banfield et al., 2001). On the other hand, in human sorbitol dehydrogenase it is a ligand 
to the Zn2+ when the enzyme is unliganded (PDB entry: 1pl7) or with NAD+ bound (PDB entry: 1pl8), but 
it is not when the enzyme is complexed with NADH and the inhibitor CP-166,572 (PDB entry: 1pl6). All 
together, this variability in Glu60 metal coordination is consistent with a dynamic zinc coordination 
ligand exchange during catalysis (Baker et al., 2009; Plapp, 2010). In this regard, the results of recent, 
thorough analyses of Zn2+ coordination in ADHs (including PDHs) from the MDR superfamily (Auld & 
Bergman, 2008; Raj et al., 2014) are also consistent with this variability. 
Another residue strictly conserved in all GPDH homologues, and strongly conserved in the MDR 
superfamily, situated close to the zinc center is Asp41. No specific role has been assigned to this amino 
acid in PDHs, although it has been well studied in yeast ADH (Ganzhorn & Plapp, 1988). In GPDH, the 
carboxyl group of Asp41 interacts with the guanidinium moiety of Arg44, and is at hydrogen bonding 
distance to two internal, highly ordered water molecules that participate in a dense network of H-bonds 
(Figure 5), and also to the hydroxyl group of Ser40. One of these latter water molecules, strongly 
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conserved in all structurally characterized PDHs, forms a hydrogen bond to His59. Therefore, it can be 
thought that Asp41, Arg44 and the latter water molecule may contribute to stabilize the geometry of the 
active site. To analyse the roles of these residues in deeper detail we have prepared several point mutants.  
Removal of the negative charge of Asp41 in the Asp41Asn mutant leads to a variant enzyme with 
unaltered Km for LG1P (Table 2) but with a dramatically decreased kcat for LG1P oxidation (from 8800 to 
250 s-1). Since this mutation involves the amidation of the carboxylate, it seems reasonable to propose that 
the ionic character of the side chain is key for its catalytic role. To analyse this aspect in deeper detail, the 
ionic interaction with Arg44 was removed in the Arg44Thr variant. The effects on the kinetic constants 
determined for this variant were similar to the Asp41Asn variant (Table 2), revealing the potential 
relevance of both residues in catalysis. Nonetheless, since Arg44 also interacts with Ser40, which is 
equivalent to Ser48 in hlADH that facilitates the deprotonation of the alcohol in this enzyme (Plapp, 
2010), the observed effects in GPDH should not be exclusively ascribed to a potential destabilization of 
the active center induced by the loss of the ionic interaction. In fact, our in silico analyses of complexes 
between GPDH and LG1P (or DG1P) strongly support the existence of direct interactions between the 
guanidinium moiety of Arg44 and both molecules. This residue would not participate in the initial 
substrate-binding steps but would assist, together with other residues, in the build-up of the correct, near-
attack conformation of the substrate (see below), which can only be attained with LG1P.  
The experimental results obtained with the second variant affecting to this residue (Arg44Tyr), 
where the introduced side chain has a similar length as the parental one, may also support such a role. 
Now, we observed a smaller effect in turnover number (decreasing from 8800 to 1700 s-1) but a 
remarkable five-fold reduction in Km for L1GP (Table 2). This suggests a direct interaction between the 
introduced side chain and the ground state of the substrate that would mainly affect to the initial LG1P-
binding steps. The less efficient LG1P oxidation would be consistent with this stronger substrate binding 
not leading to a catalytically productive conformation as efficiently as with the wild-type enzyme.  
As a whole, we believe that our results are consistent with the participation of Asp41 (together 
with the conserved water molecule) in the correct positioning of the His59 side chain; hence its 
substitution by Asn could induce structural rearrangements of the ligands to the zinc that would affect 
hydride transfer, accounting for the low kcat value observed. Conversely, the ionic, buttressing interaction 
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with Arg44 would fix this side chain such that it will be properly oriented towards the bound substrate (or 
DG1P). As a result of the established interactions, the catalytically productive complex can only be 
achieved with LG1P (see below).  
3.6. Biochemical studies
 Despite the fact that GPDH has been classically described as a dehydrogenase specific for the 
oxidation of galactitol-1-phosphate, no direct experimental evidence has been reported showing this 
specificity. Although our previous results indicating a 500-fold increase in specific activity of GPDH for 
reduction of D-tagatose-6-phosphate (DT6P) [Km = (1.00 ± 0.05) mM] versus galactitol oxidation [Km = 
(26 ± 4) mM] supported this annotation (Esteban-Torres et al., 2012), a direct characterization of the 
Zn2+- and NAD+-dependent oxidation of galactitol-1-phosphate by GPDH is required. To this end, we 
synthesized both L-galactitol-1-phosphate (LG1P) and D-galactitol-1-phosphate (DG1P). Our results 
demonstrate that GPDH exhibits a strict stereospecificity against LG1P, which together with our previous 
results on DT6P reduction, unambiguously define this enzyme as a stereospecific polyol dehydrogenase. 
Comparison of kcat and Km values for LG1P oxidation and DT6P reduction reactions reveals a higher 
turnover number for DT6P versus LG1P, but a Km for this latter substrate that makes the final specificity 
constant (kcat/Km) three-fold higher for LG1P oxidation than for DT6P reduction.  
3.7. NAD+ recognition 
 Considering our failed attempts to obtain a well-defined electron density map for the cofactor 
bound to GPDH, we carried out in silico studies of the binding mode for NAD+ to the closed state of the 
enzyme (Figure 6). In the conservative binding mode proposed, the adenine ring is located in a 
hydrophobic pocket lined by residues Ile167, Ile193, Ala237, Val239 and Thr242, whereas the attached 
ribose establishes hydrogen-bonding interactions with the side chains of Asp192 and Lys197 through its 
O2' and O3' atoms, respectively. This result agrees with the reported structural basis of the specificity for 
NAD(H) over NADP(H), which resides in the presence of an Asp residue (Asp192 in GPDH), that 
interacts with the ribose hydroxyl groups (Baker et al., 1992). The diphosphate bridge, in turn, is placed 
at the dipole plus end of helix 4 and directly interacts with residues Gly39, Thr171, Ile172, and Met338. 
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The nicotinamide riboside, on the other hand, has the pyridine ring surrounded by hydrophobic residues 
Val148, Ile172 and Val259; the amide moiety interacting with the carbonyl groups of Val259 and Ser286 
and the NH of Met288; and the ribose O4 hydroxyl engaged in a hydrogen bond both the carbonyl 
oxygen of Ala237 and the NH of Thr261.  
 Interestingly, all crystal structures of GPDH reported in this work reveal ordered water molecules 
interacting with the carbonyl groups of Val259 and Ser286 and additional ones in model 1 (that lacks a 
polyol in the active center) interacting with the main chain NH of Met288. Hence, the distribution of 
ordered waters in this region faithfully resembles the predicted position of the amide moiety of the 
nicotinamide ring bound to GPDH. Moreover, the absence of the latter water molecule interacting with 
Met288 in models 2 and 3 could be due to the presence of glycerol or Tris in the active center since the 
distal parts of these molecules protrude towards the predicted position of the nicotinamide ring, making 
the simultaneous presence of both cofactor and polyol mutually exclusive.  
3.8. GDPH substrate recognition and reaction mechanism 
 The two conformational states of the GPDH subunits may represent structures relevant to the 
catalytic mechanism of the enzyme namely the apoenzyme (open state) and the ternary complex (closed 
state), as suggested by the structural similarity to hlADH whose isomerization step has been described in 
detail (Sekhar & Plapp, 1990; Kovaleva & Plapp, 2005). Therefore we propose the following scenario for 
GPDH: in the absence of any bound ligand there would exist an equilibrium between the open and the 
closed states of the enzyme. In both cases, the zinc ion is tetra-coordinated by two protein side chains 
(Cys38, His59) and two water molecules. The required cofactor NAD+ would bind the closed state of the 
enzyme first (conformational selection model), followed by the binding of LG1P. LG1P binds with both 
its C5 and C6 oxygen atoms coordinated to the zinc, with the concurrent release of a water molecule: zinc 
ligand exchanges would then yield a penta-coordinated metal ion (model 3). Our in silico model of the 
ternary complex (Figure 7) shows that LG1P stacks in part against the nicotinamide ring and this is 
consistent with an ordered mechanism.  
 The proton transfer from the C5 hydroxyl group of LG1P required for LG1P oxidation to DT6P 
demands a base, a role which, for hSDH (Pauly et al., 2003) and sheep liver SDH (Klimacek et al., 2007), 
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has been assigned to the water molecule that in GPDH interacts with Glu60 and Glu144. Based on our 
structural and functional analyses, we claim that the catalysis by GPDH is consistent with the generally 
accepted mechanism proposed by Cui et al. (2002) [see also (Plapp, 2010) for a review]. In this scenario, 
the hydroxyl group of Ser40 in GPDH  (Ser or Thr residues systematically appear in this position in 
PDHs) acts as part of the relay system that transfers the proton of the C5 hydroxyl group to the bulk 
water. The predicted conformation of bound LG1P indicates that upon Zn2+ coordination by the substrate, 
most likely funnelled by the strong hydrogen bond between primary C6 hydroxyl group and the 
carboxylate of Glu144, the orientation of the secondary C5 hydroxyl group is adequate for such a proton 
transfer exclusively for LG1P. The participation of Ser40 in catalysis can be inferred from the kinetic 
parameters determined for the variant Ser40Ala: while Km for LG1P remains essentially unaltered, an 
important reduction in the turnover number is observed (from 8800 to 1500 s-1) (Table II), which is 
consistent with the assigned role in abstracting the proton from the C5 hydroxyl group of the substrate. 
Subsequent hydride transfer from C5 to the pyridine ring of the NAD+ coenzyme, facilitated by the 
polarization of the C5−O5 bond due to the specific Zn2+ coordination to NAD+, and only possible for 
LG1P, would lead to cofactor reduction and oxidation of the C5 hydroxyl to the keto group of DT6P.  
 Although according to the substrate-binding mode many residues contribute to the definition of 
the complete substrate-binding pocket (Cys38, Ser40, Arg44, His51, His59, Tyr106, Phe108, Ser111, 
Arg112, Glu144, Trp287, Met288), we observe that two residues, namely Arg44 and Met288, would 
directly interact with LG1P: Arg44 would interact with C4 hydroxyl group and Met288 would establish 
hydrophobic interactions with the C4-C5-C6 backbone atoms of LG1P (Figure 7). Hence, a role in 
substrate orientation (that will ultimately lead to enantiomer discrimination) can be predicted for them. 
The important role in catalysis of Arg44 could be inferred from the two variants discussed above 
(Arg44Thr and Arg44Tyr), and that of Met288 was checked with the Met288Arg variant, which revealed 
a drastic decrease in kcat for LG1P oxidation (similar to that observed for the Arg44Thr variant), with Km
remaining unaltered.  
 It is worth mentioning that the configuration of the substrate-binding pocket is compatible with 
DG1P binding (Figure 7). However, the predicted interactions established with Zn2+, Glu144 carboxylate, 
Arg44 and Met288 would lead to a conformation incompatible with both proton transfer, due to the 
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improper orientation of the secondary C5 hydroxyl group relative to Ser40, and hydride transfer, since the 
C5 H atom would be oriented away from the pyridine ring of the NAD+ coenzyme. Inhibition of LG1P 
activity by increasing concentrations of DG1P could be demonstrated in biochemical analysis. From 
Lineweaver-Burke-plots of inhibition kinetics, a competitive inhibition by DG1P can be deduced because 
the intersection of the plots is close to the reciprocal velocity axis. The Km for LG1P oxidation is highly 
affected and drops almost 6-fold by addition of 3mM DG1P while the reaction velocity is only reduced by 
20% (Figure S1). 
 Also, we propose that three residues of the pocket, namely His51, Tyr106 and Arg112, are also 
important in substrate specificity by playing a bait role for attracting the phosphate group, and probably 
facilitating product release as well. This proposal is supported by available structural evidence and results 
from our molecular dynamics simulations (data not shown) revealing that these residues can be oriented 
towards the solvent (open state) or towards the active site (closed state). The finding that site-directed 
mutagenesis at these three positions resulted in enzymes displaying decreased turnover numbers but Km
values similar to those of the wild-type enzyme (Table II) appears to support this assigned function. 
Finally, these same studies also revealed that the Arg278 side chain from one subunit might be also 
engaged in the fixation of the phosphate moiety of the substrate by the other subunit, suggesting the 
existence of a cross-talk between subunits that is currently under investigation. 
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Table 1 
Data-collection and refinement statistics for GPDH structures.  
Values in parentheses are for the last shell. 
 GPDH:Zn2+
(model 1) 
GPDH:Zn2+:Tris 
(model 2) 
GPDH:Zn2+:glycerol 
(model 3) 
Data statistics 
  Beamline BL13-XALOC ID29 ID23-1 
  Wavelength (Å) 1.2824 1.2815 0.9688 
  Space group P21 P21 P21
  a, b, c (Å) 43.3, 76.9, 108.6 65.6, 78.9, 68.6 65.3, 78.8, 68.2 
α, β, γ (º) 90.0, 95.5, 90.0 90.0, 94.6, 90.0 90.0, 94.7, 90.0 
  Resolution (Å) 2.0 1.9 1.7 
  Completeness (%) 97.8 (96.0) 89.7 (54.7) 99.2 (98.7) 
  No. of observed reflections 160822 299907 483893 
  No. of unique reflections  47058 49264 70089 
  Rp.i.m. (%) 4.3 (41.1) 5.1 (29.6) 4.0 (25.3) 
〈I/σ(I)〉 8.7 (1.8) 7.9 (2.3) 11.2 (3.2) 
  Wilson B value (Å2) 31.3 11.9 15.4 
Refinement statistics    
  Resolution limits (Å) 44.2 (2.0) 45.2 (1.9) 41.7 (1.7) 
  Z 2 2 2 
  No. of reflections used 44566 46624 66417 
  Rcryst (%) 19.5 20.2 18.5 
  Rfree§ (%) 25.6 25.8 22.8 
  No. of atoms    
    Protein 5254 5270 5349 
    Ligands 5 7 7 
    Water 276 471 654 
  Average B factor (Å2)     
    Protein    
      Chain A 50.7 22.8 23.6 
      Chain B 60.9 24.6 19.5 
    Ligands    
      Zn2+ 85.5 27.9 18.6 
      Tris --- 30.2 --- 
      Glycerol --- --- 31.1 
   Water oxygen 49.7 32.4 33.2 
  R.m.s.d., bond lengths (Å) 0.009 0.008 0.007 
  R.m.s.d., bond angles (º) 1.28 1.16 1.11 
  Ramachandran Plot    
    Favoured (%) 91.7 97.1 96.9 
    Allowed (%) 6.4 2.9 2.9 
    Outlier (%) 1.9 0 0.2 
  PDB code 4ueo 4uek 4uej 
Rp.i.m. = hkl{1/[N(hkl)  1})1/2 i Ii(hkl)  〈I(hkl)〉 / hkl i Ii(hkl). 
Rcryst = hkl ⏐Fobs  Fcalc⏐/ hkl Fobs. §Rfree is the cross validation R factor for the 5% of the 
reflections against which the model was not refined.
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Table 2 
Kinetic parameters for wild-type GPDH and single-point variants 
Variant Substrate Km (mM) kcat (1/s) kcat/Km [1/(s· M)]  
Wild-type Galactitol 26 ± 4 37 1400 
Wild-type LG1P 0.16 ± 0.03 8800 55.0 ·106
Wild-type DT6P 1.00 ± 0.05 19500 19.5 ·106
Ser40Ala LG1P 0.14 ± 0.01 1500 10.7 ·106
Asp41Asn LG1P 0.17 ± 0.08 250 1.5 ·106
Arg44Thr LG1P 0.15 ± 0.01 170 1.1 ·106
Arg44Tyr LG1P 0.033 ± 0.001 1700 51.5 ·106
His51Ala LG1P 0.17 ± 0.01 2500 14.7 ·106
Tyr106Ala LG1P 0.20 ± 0.02 3000 15.0 ·106
Arg112Ala LG1P 0.09 ± 0.01 2700 30.0 ·106
Met288Arg LG1P 0.23 ± 0.01 1200 5.2 ·106
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Figure captions 
Figure 1. Multiple amino acid sequence alignment of GPDH with the closest structural homologs: zinc-
binding dehydrogenase from Sinorhizobium meliloti (4ejm), threonine dehydrogenase from Pyrococcus 
horikoshii (2dfv), sorbitol dehydrogenase from silverleaf whitefly (1e3j), threonine 3-dehydrogenase 
from Thermus thermophiles (2dq4), L-threonine dehydrogenase from Thermococcus kodakaraensis
(3gfb) and human sorbitol dehydrogenase (1pl8). Secondary structural elements of GPDH according to 
DSSP are indicated as orange arrows (-strands) and green cylinders (-helices). In the upper part an 
overall view of GPDH (represented as ribbon model) is shown indicating the locations of the catalytic and 
the structural zincs (green spheres) and the relative orientation of the GPDH subdomains. 
Figure 2. Main contacting interface between GPDH subunits. A subunit is shown as an orange surface 
and the accompanying subunit as a ribbon models. The principal structural elements that participate in 
intersubunit interactions are strands 13 and 14 and helix 8 from both subunits.  
Figure 3. Representation of the regular secondary structural elements of GPDH that delimitate an internal 
cavity situated at the main contacting interface between subunits. (a) Two orthogonal views of such 
structural elements (helices and strands from one subunit are shown as green cylinders and cyan arrows, 
respectively, and as magenta cylinders and yellow arrows from the other subunit). (b) Close-up view of 
the cavity showing the side chains of the residues facing its lumen. All residues are hydrophobic. Since 
the cavity exhibits a two-fold symmetry, only unique residues are indicated for simplicity.  
Figure 4. Zinc coordination observed in the different GPDH complexes. (a) Structural zinc in the lobe 
loop. The structural zinc is shown as a green sphere. The electron density for Zn2+ (orange) is derived 
from an anomalous map (5 level) prepared from data collected at the zinc peak (9.667 keV; 1.28245 Å 
wavelength) and that for the ligands is a composite omit map (1 level) calculated with phenix. (b) 
Catalytic zinc ligands in GPDH preincubated with the metal (model 1). The zinc (shown as a grey sphere) 
is coordinated by interactions with Cys38, His59 (stick representation) and two water molecules (red 
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spheres). The electron density maps are as in panel (a). (c) Catalytic zinc ligands in GPDH with bound 
Tris. The ligands are Cys38, His59 a conserved water molecule (red sphere) and a hydroxyl group of the 
Tris molecule. The electron density map is a composite omit map contoured at 1 level (for clarity the 
electron density for Tris is shown as an orange mesh). (d) Catalytic zinc ligands in GPDH with bound 
glycerol. The metal is penta-coordinated by Cys38, His59 a conserved water molecule (red sphere) and 
two hydroxyl groups of the glycerol molecule. A strong hydrogen bond between the one primary OH 
group of glycerol and the carboxylate moiety of Glu144 is represented. In all cases, potential hydrogen 
bonds are represented as dashed lines. Distances are indicated in Å. 
Figure 5. The active site of GPDH. Details of the interactions established between the catalytically 
important residues Ser40, Asp41 and Arg44, and location of the internal, ordered water molecules (these 
molecules also appear in model 2). The composite omit map around these water molecules (contoured at 
1 level) is also shown. Potential hydrogen bonds are represented as dashed lines, and the ionic 
interaction between Arg44 and Asp41 as a magenta dotted line. Distances are indicated in Å. 
Figure 6. The ternary GPDH-LG1P-NAD+ complex. GPDH residues from the substrate-binding site (see 
the text) are shown in stick representation, as are the substrate (LG1P) and the coenzyme (NAD+). The 
guanidinium moiety of the Arg278 side chain from the accompanying subunit (cyan sticks) interacts with 
the phosphate moiety of the substrate. The first coordination sphere of the catalytic zinc (that appears as a 
purple sphere) is completed by Cys38, His59, a conserved water molecule and the C5 and C6 oxygen 
atoms from LG1P. The C5 H atom to be transferred as hydride to the pyridine of NAD+ during the 
catalytic cycle is shown in cyan. 
Figure 7. Orientation of LG1P and DG1P in the catalytic center of GPDH. (a) The complex determined 
for LG1P is compatible with catalysis by GPDH: first, the proton of the C5 hydroxyl group of DG1P is to 
the side chain of Ser40 that together with the C2D hydroxyl group of the ribose moiety from the NAD+
cofactor would constitute the proton relay system of GPDH and second, the C5 H atom is located facing 
the pyridine ring of the NAD+ coenzyme, satisfactorily oriented for hydride transfer to the C4 atom of the 
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pyridine moiety. (b) The complex with DG1P is incompatible with catalysis by GPDH. The restrictions 
imposed by the amino acid side chains configuring the substrate-binding pocket together with the zinc ion 
impede the formation of a catalytically productive complex (see the text for further details).     
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